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SUMMARY
Hypothalamic melanocortin neurons play a pivotal role in weight regulation. Here, we examined the contribution of Semaphorin 3 (SEMA3) signaling to the development of these circuits. In genetic studies, we found 40 rare variants in SEMA3A-G and their receptors (PLXNA1-4; NRP1-2) in 573 severely obese individuals; variants disrupted secretion and/or signaling through multiple molecular mechanisms. Rare variants in this set of genes were significantly enriched in 982 severely obese cases compared to 4,449 controls. In a zebrafish mutagenesis screen, deletion of 7 genes in this pathway led to increased somatic growth and/or adiposity demonstrating that disruption of Semaphorin 3 signaling perturbs energy homeostasis. In mice, deletion of the Neuropilin-2 receptor in Pro-opiomelanocortin neurons disrupted their projections from the arcuate to the paraventricular nucleus, reduced energy expenditure, and caused weight gain. Cumulatively, these studies demonstrate that SEMA3-mediated signaling drives the development of hypothalamic melanocortin circuits involved in energy homeostasis.
INTRODUCTION
Neural circuits in the hypothalamus play a critical role in the regulation of energy homeostasis (Elmquist et al., 1998) . The hypothalamic melanocortin circuit is formed by leptin-responsive neurons in the arcuate nucleus of the hypothalamus (ARH) expressing either pro-opiomelanocortin (POMC) or Neuropeptide Y (NPY)/Agouti-related protein (AgRP), which project to, and synapse with, melanocortin-4 receptor (MC4R)-expressing neurons in the paraventricular nucleus of the hypothalamus (PVH). In the nutritionally replete state, ARH POMC neurons release melanocortin peptides, including a-melanocyte-stimulating hormone (a-MSH), which act as agonists at MC4R to reduce food intake and increase energy expenditure (Cowley et al., 2001) . Genetic disruption of POMC and MC4R leads to severe obesity in rodents (Huszar et al., 1997; Yaswen et al., 1999) and humans (Krude et al., 1998; Vaisse et al., 1998; Yeo et al., 1998) , emphasizing the critical role of this melanocortin circuit in energy homeostasis.
Here, we studied the development of hypothalamic melanocortin circuits, focusing on the contribution of the class 3 Semaphorins (Pasterkamp, 2012 ) (SEMA3A-G), which direct the development of gonadotropin-releasing hormone (GnRH) neurons into the hypothalamus (Cariboni et al., 2015; Hanchate et al., 2012) . Disruption of Sema3 signaling impairs the development of GnRH projections in mice and rare variants that disrupt SEMA3 signaling are associated with hypogonadotropic hypogonadism in humans (Cariboni et al., 2015; Young et al., 2012) . We performed genetic studies in people with severe obesity to test whether there was an enrichment of rare potentially functional variants in genes encoding the SEMA3s and their receptors compared to controls. We found 40 rare variants in these genes; 34 altered the function of these proteins through multiple molecular mechanisms. To test whether disruption of Sema3 signaling can perturb energy homeostasis, we performed a CRISPR/Cas9 mutant screen of these genes in zebrafish. We showed that disruption of 7 genes caused increased somatic growth and/or adiposity. Using hypothalamic explants from mice, we demonstrated that Sema3 signaling via Nrp2 receptors drives the development of Pomc projections from the ARH to the PVH. Deletion of Nrp2 in Pomc neurons, reduced the density of Pomc projections and caused weight gain in young mice. Together, these findings demonstrate the role of Sema3 signaling in the development of melanocortin circuits that modulate energy homeostasis, findings that have relevance to the understanding of disorders of human hypothalamic development.
RESULTS

Identification of Rare Variants in Semaphorin 3 Ligands and Their Receptors in Severely Obese Individuals
We hypothesized that if the genes encoding Sema3s and their receptors (SEMA3A-G, NRP1-2, and PLXNA1-4) contribute to the development of neurons that regulate body weight in humans, we might identify functional variants in these genes in people with severe early onset obesity. We examined exome sequencing data from 573 individuals with severe early onset obesity (BMI SDS > 3; onset under 10 years of age) recruited to the Genetics of Obesity Study (GOOS) studied as part of the UK10K consortium (Hendricks et al., 2017; Walter et al., 2015) . We found 40 rare variants in these 13 genes (Table 1) . To test whether there was an enrichment for very rare (minor allele frequency < 0.025%) predicted functional variants in 13 genes involved in Semaphorin 3 signaling in severely obese cases compared to controls, we compared exome sequencing data from the final UK10K data release of 982 severely obese individuals (including the 573 individuals in whom the first 40 variants were identified) with that of 4,449 healthy controls recruited to the INTERVAL study (Moore et al., 2014) . After adjusting for multiple testing, we found that very rare predicted functional variants in this cluster of genes were enriched in severely obese cases compared to controls (OR = 1.40, p-adjusted = 0.02; Tables S1  and S2 ). Although suggestive, these associations were not statistically significant at the single gene level after adjusting for multiple testing. Given the rarity of variants, larger sample sizes will be needed to test whether the burden of rare variants in specific genes or combinations of genes is greater than expected in severely obese cases versus controls.
Rare Variants in SEMA3s Affect Their Secretion and Function in Cells
We performed experiments in cells to dissect the functional consequences of very rare human variants (Figures 1 and S1; Table S3 ). SEMA3A-G are secreted as disulphide bridge-linked dimers and processed by furin ( Figure 1A ). SEMA3s (except SEMA3E) bind to Neuropilin co-receptors (NRP1 and NRP2) in hetero-complexes with PlexinA1-4 (PLXNA1-4) receptors to activate plexin signal-transduction (SEMA3E can signal without NRPs through the class D plexin, PLXND1) (Janssen et al., 2012; Tran et al., 2007) . The dimeric SEMA3s form the signaling complex with two PLXNAs and NRPs, the NRPs cross-bracing the interfacing SEMA3s and PLXNAs (Janssen et al., 2012) . We mapped the 19 variants in SEMA3s onto the crystal structure of SEMA3A and homology models of SEMA3B-3G to suggest structural explanations for our findings ( Figure 1A ). To assess whether SEMA3s mutants affect protein secretion, we quantified the amount of secreted SEMA3 detected in the medium of HEK293 cells transiently transfected with Flag-tagged wild-type (WT) or mutant SEMA3 by ELISA. Six mutants decreased protein secretion compared to WT SEMA3 (Figure 1B) . Most led to increased intracellular retention of mutant SEMA3, suggesting that the defect was in secretion rather than synthesis ( Figure S1A ). In contrast, six mutants led to increased protein secretion (Figures 1B and S1B) . The SEMA3G R728C variant may hinder SEMA3 dimerization by disrupting the formation of an intersubunit disulfide bridge by the proximal, conserved cysteine residue C726 ( Figures 1A and S1C ). (B) ELISA analysis of C-FLAG-tagged WT/mutant SEMA3A-G secreted in the medium (a.u., arbitrary units).
(C) Effect of WT/mutant SEMA3A-G on cell collapse normalized to amount of semaphorin secreted. (D) Structural analysis of SEMA3 mutants affecting cell collapse (increased, blue; decreased, red). Mutants are mapped on the crystal structure of the mouse Sema3A-Nrp1-PlxnA2 complex (PDB: 4GZA). Data represented as mean ± SEM from at least three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 for all experiments. See also Figure S1 and Table S3 . To test whether SEMA3 mutants affect receptor-mediated signaling and thus disassembly of the actin cytoskeleton and cellular collapse, U97MG cells were treated with medium from cells transfected with WT or mutant SEMA3s, and the number of collapsed cells counted. Compared to WT SEMA3s, 9 of the 19 SEMA3 mutants affected cell collapse ( Figure 1C ; Table  S3 ). Five SEMA3D mutants induced less collapse than WT ( Figure 1C ).
Based on homology modeling, 12 of 19 variants were predicted to affect secretion and/or cellular collapse due to destabilization of the Sema domain important for SEMA3-PLXNA-NRP recognition ( Figure 1D ). Paradoxically, four mutants decreased collapse despite increased secretion. SEMA3C R739Q and SEMA3D R265H both locate close to the SEMA3-NRP interface and may thus weaken SEMA3C-NRP1/2 binding. SEMA3D R773G may destabilize the SEMA3-PLXNA-NRP complex by affecting the charge distribution on the basic tail. SEMA3E R167G, located at the SEMA3-PLXNA interface, may directly affect PLXN binding ( Figure 1D ). Two SEMA3B mutants showed decreased secretion, yet increased collapse even after adjustment for the amount of protein secreted ( Figures 1B, 1C , S1D, and S1E). In summary, 15 of the 19 variants have functional consequences on the protein by affecting secretion and/or collapse in these assays (Table S3 ).
Rare Variants in NRP1-2 and PLXNA1-4 Disrupt Cell-Surface Localization and Function
We examined the molecular mechanisms by which the 21 variants in PLXNA1-4 and NRP1-2 might affect their function (Figures 2 and S2) . HEK293 cells were transfected with N-terminally GLU-GLU-tagged WT and mutant constructs. Surface localization of NRPs and PLXNs on non-permeabilized cells was quantified by ELISA using an anti-GLU-GLU antibody. One NRP2 mutant (A506V) and 17 of the 18 PLXNA mutants significantly decreased cell-surface expression compared to WT receptors (Figures 2A and S2A ). WT PLXNA1, A2, and A4 were predominantly localized on the plasma membrane, whereas mutant PLXNs with reduced cell-surface expression were predominantly found within the endoplasmic reticulum (ER) ( Figure S2B ). Interestingly, both WT and mutant PLXNA3 were localized in the ER ( Figure S2B ). Almost all mutants with decreased cell-surface localization reduced cell collapse in cells transfected with NRP or PLXN ( Figure 2B ). In a ligand binding assay, none of the mutants affected the equilibrium dissociation constant of the interaction ( Figure S2C ); only NRP2 A506V decreased total binding (Figure 2C) , in agreement with its modest decrease in cell-surface expression. Co-expression of NRP mutants with each WT PLXN gave similar results as with expression of NRP alone (Figures 2C and S2C) .
Structural modeling of the 21 mutants in PLXNAs and NRPs (Figures 2D-2F) suggested possible explanations for protein misfolding. Six of the 11 mutants lie in the Sema domain of the PlxnA ectodomains; however, they are not at the Sema3 and Nrp-binding surfaces, so are likely to affect structural stability rather than ligand or co-receptor interactions ( Figure 2D ). Mutants on the PSI and IPT domains may disrupt the stability of these domains ( Figure 2D ). PLXNA3 D127N is located on a surface that mediates PlxnA-PlxnA interactions important for receptor auto-inhibition pre-ligand binding (Kong et al., 2016) ( Figures  S2D and S2E ). Six mutants lie in the cytoplasmic Plxn domains and may additionally affect coupling to downstream signaling molecules; PLXNA1 L1278F on the juxta-membrane helices may affect pre-signaling inhibition, PLXNA3 D1710N on the Rap-GAP pocket helices may affect Rap binding, PLXNA1 G1650S, and PLXNA4 T1642I on the Rho-GTPase binding domain (RBD) may affect interactions with the Rho-GTPases and PLXNA3 T1679I may disrupt the hydrophobic core of the PlxnA GAP domain ( Figure 2E ). Only 1 of the 3 mutants found on NRP1 and NRP2 lead to decreased cell collapse and reduced cell-surface expression likely by affecting molecular stability ( Figure 2F ).
A Mutagenesis Screen in Zebrafish Demonstrates that Disruption of Semaphorins, Plexins, and Neuropilins Alters Somatic Growth and Adiposity
We used zebrafish to test whether altered Sema3 signaling can disturb energy homeostasis, as the hypothalamic neural circuits involved in energy homeostasis are highly conserved (Leibold and Hammerschmidt, 2015; Minchin and Rawls, 2017) . Multiple CRISPR guide RNAs (gRNAs) targeting distinct regions of each zebrafish semaphorin 3, neuropilin, and plexin a ortholog ( Figures 3A and S3A ) were injected into one-cell stage zebrafish embryos. Disruption of the melanocortin system can influence both somatic growth and adiposity in zebrafish (Sebag et al., 2013; Zhang et al., 2012) . Deletions in seven genes significantly increased somatic growth, body weight and/or the percentage of body fat ( Figures 3B and S3B ). Deletion of a duplicate gene for NRP2 (nrp2b) increased adiposity and somatic growth ( Figure 3C ). In contrast, deletions of two genes decreased percentage of body fat. Cumulatively, these data demonstrate that Semaphorin 3 signaling can affect energy homeostasis, potentially through several different mechanisms.
SEMA3s and Their Receptors Are Expressed in the Hypothalamus during Early Development
Using qRT-PCR we found that Nrp1-2 and PlxnA1-4 mRNAs were detected in the mouse hypothalamus as early as E10 and were highly expressed postnatally, particularly in the ARH (Figures 4A and S4A) . NRP1-2 and PLXNA1-4 mRNAs were also expressed in the human fetal hypothalamus and the hypothalamus of human young adults ( Figure 4A ). Sema3a, Sema3c, Sema3e, and Sema3f were expressed in the mouse PVH at P10 (Figure 4A) ; SEMA3C was the most abundant in the mouse PVH, RBD, Rho GTPase-binding domain; GAP, GTPase-activating protein; TM, transmembrane; JM, Juxtamembrane. The neuropilin ectodomain comprises two CUB domains (a1 and a2), two coagulation factor V/VIII homology domains (b1 and b2) and a MAM domain, L, linker. In (D)-(F), variants causing decreased surface expression (red), no effect on surface expression (gray), decreased surface expression as well as decreased cell collapse (blue) are shown. Data represented as mean ± SEM from at least three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S2 . DMH, ARH, and preoptic area ( Figure S4A ) and in the human fetal and young adult hypothalamus ( Figure 4A ). This temporal pattern of gene expression overlaps with a critical time window for the development of the melanocortin circuits that regulate energy homeostasis. Pomc neurons in the ARH are generated on embryonic day (E)11-12, acquire their terminal peptidergic phenotype during mid-late gestation (Padilla et al., 2010) and send axonal projections to their target sites during the first few weeks of postnatal life .
Sema3s Drive the Growth of Pomc Projections In Vitro
To test whether Sema3s are involved in the development of arcuate Pomc projections, we performed co-cultures between ARH explants derived from Pomc-Cre; TdTomato mice (to genetically label Pomc axons) and HEK293 cell aggregates transfected with human SEMA3-encoding vectors ( Figure 4B ). We quantified the density of axons extending toward (proximal) or away (distal) from cell aggregates ( Figure 4B ). Compared with the radial growth seen with HEK293 cells transfected with an empty vector, growth of arcuate Pomc axons was enhanced by HEK293 cell aggregates overexpressing SEMA3A, SEMA3B, SEMA3C, SEMA3D, and SEMA3G ( Figure 4C ). Notably, only SEMA3C and SEMA3D affected the growth of arcuate NPY axons ( Figure S4B ). To validate the specificity of our in vitro assay, we co-cultured an explant derived from the dorsal root ganglion (DRG) with HEK293 cells overexpressing SEMA3A and confirmed, as previously described (Taniguchi et al., 1997) that SEMA3A inhibited the growth of DRG axons ( Figure S4C ). Together, these observations demonstrate that SEMA3s can signal to ARH axons, including to Pomc axons, and display enhanced growth. We repeated co-cultures between mouse ARH explants and HEK293 cell aggregates transfected with a subset of human SEMA3 variants and evaluated axon growth. Three of five variants tested negatively affected the overall growth of arcuate axons; one increased the density of POMC projections (Figure 4D) . Interestingly, SEMA3G E478D and SEMA3B P296L mutants specifically reduced POMC axon growth.
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Neuropilin Receptors Mediate the Growth of Arcuate Pomc Projections toward the PVH and away from the VMH We reconstructed arcuate connections in vitro by co-culturing two explants derived from different hypothalamic nuclei. When an ARH explant derived from Pomc-Cre; TdTomato mice was co-cultured with a PVH explant, the density of fibers directed toward the PVH was substantially greater than that from the opposite side of the ARH, suggesting that the PVH releases diffusible chemotropic factors that promote growth of arcuate Pomc axons ( Figure 4E ). Substitution of the PVH explants with control HEK293 cells or an explant derived from the cortical cortex (normally not innervated by ARH axons) did not result in any detectable effect on neural projections ( Figures 4E and S4D) , demonstrating a high degree of specificity. Nrp1 or Nrp2 neutralizing antibodies blocked the induction of growth exerted by the PVH on arcuate Pomc axons ( Figure 4E ). The DMH promoted growth of arcuate Pomc axons, but this effect was not blocked with Nrp1-or Nrp2-neutralizing antibodies ( Figure 4E ). In contrast, the VMH inhibited growth of arcuate Pomc axons and this effect was blocked by the addition of Nrp1, but not Nrp2, antibodies ( Figure 4E and S4E) . Thus, Nrp-mediated signaling plays a specific role in establishing Pomc axonal projections to the PVH.
Genetic Deletion of Neuropilin 2 Reduces the Density of Pomc Projections to the PVH and Causes Weight Gain in Mice
In the ARH, Nrp2 mRNA expression was 2 times higher than that of Nrp1 ( Figure 4A ). To investigate the role of Nrp2 in Pomc neurons in vivo, we crossed mice carrying a Nrp2 loxP allele (Walz et al., 2002) with mice expressing Cre recombinase in a Pomcspecific manner (Pomc-Cre) (Balthasar et al., 2004) to generate mice that lack Nrp2 in Pomc-derived neurons. We repeated the in vitro co-culture assay with an ARH explant derived from Nrp2 loxP/loxP mice that received intra-ARH injections of an AAV-Cre vector and a PVH explant derived from WT mice. Genetic loss of Nrp2 in ARH neurons also blocked growth of axons toward the PVH ( Figure 4F ). As expected, the levels of Nrp2 mRNA were decreased in the arcuate nucleus of Pomc-Cre; Nrp2 loxP/loxP mice whereas the levels of Nrp1 were comparable between control and mutant mice ( Figure S5A ); there was a 3-fold reduction in Nrp2 mRNA in sorted POMC neurons derived from mutant mice ( Figure 5A ). In contrast, there was no significant change in the levels of Nrp1 and Nrp2 mRNAs in the pituitary of mutant mice ( Figure S5B and S5C) , or in other hypothalamic nuclei and extra-hypothalamic brain regions ( Figure S5D ).
Pomc-Cre; Nrp2 loxP/loxP mice were born normally and had body weights indistinguishable from control littermates until 11 weeks of age ( Figure 5B ) when mutant mice displayed significantly higher body weights ( Figure 5B ). Oxygen consumption (VO 2 ), locomotor activity and energy expenditure were reduced in mutant mice compared with control Nrp2 loxP/loxP mice ( Figures  5C-5E ). Although there was no change in body composition (Figure 5F) , there was an increase in adipocyte size in mutant mice ( Figure 5G ). Food intake and respiratory exchange ratio were not significantly different compared to controls (Figures 5H and (B) In a co-culture system to evaluate neural growth, the average density of neurites in the proximal and distal parts of the ARH explant (with respect to the target tissue, e.g., PVH) is compared to quantify the density of axons extending toward (proximal) or away (distal) from cell aggregates. (C) ARH explants from Pomc-Cre; TdTomato mice were co-cultured with an aggregate of HEK293 cells overexpressing Sema3A-G and immunostained with TUJ1 (neuron-specific class III beta-tubulin). (D) Quantitative analysis of TUJ1 + (upper panel) and Pomc + (lower panel) axons derived from arcuate explants co-cultured with an aggregate of HEK293 cells overexpressing SEMA3A-G mutants (*p < 0.05 versus mock; # p < 0.05 versus WT). ARH, arcuate nucleus. (E) ARH explants derived from Pomc-Cre, TdTomato mice were co-cultured with explants containing the PVH, DMH, or VMH and Nrp1 or Nrp2 blocking antibodies (a). Data represented as mean ± SEM. *p < 0.05 versus mock; D, p < 0.05 versus PVH immunoglobin (IgG); $, p < 0.05 versus VMH IgG. (F) ARH explants derived from Nrp2 loxP/loxP mice that received intra-ARH injections of an AAV-Cre vector with explants containing the PVH. Genetic loss of Nrp2 in the ARH causes a significant reduction in ARH axon growth. **p < 0.01 versus control. Scale bars, 250 mm (B) and 100 mm (D and E). See also Figure S4 . (legend continued on next page) 5I). Pomc-Cre; Nrp2 loxP/loxP mice displayed elevated levels of glucose 15 min after a glucose challenge, compared to control mice ( Figure 5J ). Leptin levels, but not insulin, T3, T4, and corticosterone levels, were significantly elevated in mutant mice (Figures S5E-S5I ).
Although the overall distribution of aMSH-IR fibers was similar between mutant and control mice, the density of aMSH-IR fibers innervating the neuroendocrine and pre-autonomic parts of the PVH of Pomc-Cre; Nrp2 loxP/loxP mice was 2-to 3-fold lower than that observed in the Nrp2 loxP/loxP mice ( Figure 5K ). The density of aMSH projections to the DMH (Figure 5K) as well as to other major terminal fields ( Figure S5J ) was comparable between mutant and control mice. Corticotrophin-releasing hormone (Crh) and thyrotrophin-releasing hormone (Trh) expression in the PVH was increased, but oxytocin mRNA levels were unchanged ( Figure 5L ). The number of Pomc mRNA-expressing cells in the ARH of Pomc-Cre; Nrp2 loxP/loxP mice was comparable to that of control mice (Figures 5M and S5K-S5M). Together, these data indicate that Nrp2 signaling directs the formation of Pomc projections to the PVH with marked target specificity.
DISCUSSION
In this study, we identified rare heterozygous variants in SEMA3s, their receptors and co-receptors in individuals with severe early-onset obesity. In zebrafish, we showed that deletion of several genes in this pathway increased weight-related phenotypes establishing a role for these molecules in energy homeostasis. These genes might modulate body weight and/or fat mass by several potential mechanisms. In mice, we showed that Sema3s acting via Nrp2 direct the development of Pomc projections from the arcuate to the paraventricular nucleus of the hypothalamus. A role for Nrp1-mediated signaling in preadipocyte differentiation has been demonstrated (Ceccarelli et al., 2018) . In zebrafish, plxnd1 has been shown to regulate adipose tissue growth by affecting the formation of the extracellular matrix , indicating that Semaphorin 3 signaling may affect non-neural mechanisms that contribute to adiposity.
Rare Variants in the SEMA3s, Their Receptors, and Co-receptors
We found multiple rare variants in the genes encoding ligands, receptors, and co-receptors involved in Sema3 signaling by studying severely obese individuals. Variants were not fully penetrant and did not segregate with severe obesity in families demonstrating non-Mendelian inheritance. There are parallels with hypogonadotropic hypogonadism, where incomplete pene-trance and variable expressivity within and across families has been observed (Cassatella et al., 2018) . As the number of genes implicated in hypogonadotropic hypogonadism has increased, it has become clear that oligogenic inheritance (i.e., more than one gene mutated in the same individual) can in part explain these observations. Indeed, heterozygous variants in SEMA3A, SEMA3E, and PLXNA1 can contribute to hypogonadotropic hypogonadism in an oligogenic manner with variable penetrance (Cariboni et al., 2015; Hanchate et al., 2012) . In this study, while variant carriers did not carry additional variants in known obesity genes, it is plausible that other, as yet unidentified, genes may contribute to expression of the obesity phenotype in the individuals studied here.
Many challenges when studying rare variants might contribute to complex traits that do not follow Mendelian patterns of inheritance (Agarwala et al., 2013; Zuk et al., 2014) . Statistical burden association tests are used to test for a difference in the load of rare variants predicted to have a functional impact in cases versus controls. Using this approach, we found nominal enrichment for very rare variants in the cluster of genes encoding SEMA3 ligands, receptors, and co-receptors when severely obese cases were compared to healthy controls indicating that rare variants within this gene-set may be associated with obesity. However, given the number of rare variants, their presence in cases and in controls, and the complexity of Sema3 signaling, larger genetic studies are needed to more fully test whether the burden of functionally significant variants (as tested in cells) is increased in severely obese individuals compared to controls and whether this association is driven by specific genes/combinations of genes. Some of the neurodevelopmental phenotypes observed in variant carriers overlap with those seen in animals (Table 1) . One male carrying PLXNA3 D1710N had hypogonadotrophic hypogonadism. As PLXNA3 lies on the X chromosome, this individual would have minimal residual signaling through PLXNA3. The true prevalence of hypogonadotrophic hypogonadism among variant carriers may be underestimated here as several probands were pre-pubertal children.
SEMA3 signaling is known to regulate the development of the enteric nervous system in rodents and rare heterozygous loss of function variants in SEMA3C and SEMA3D have been associated with Hirschsprung's disease in humans (Jiang et al., 2015) , a disorder characterized by failure of development of parasympathetic ganglion cells in the large intestine. Five people had severe medication-resistant constipation in childhood with multiple hospital admissions; two individuals had been investigated for Hirschsprung's disease and one required a colostomy for severe dysmotility (SEMA3D D640Y). Additional studies in neuronal cells, experimental animal models of human variants, Figure S5 . and in variant carriers will be needed to directly test the functional impact of these variants on the development of the enteric nervous system.
Insights into the Molecular Mechanisms Disrupted by Rare Human Variants
Many of the SEMA3 variants reduced secretion and/or receptormediated signaling. In blinded studies, four mutants that had functional consequences on secretion and/or signaling in cells affected the density of neuronal projections, while the one WT-like variant (SEMA3D D640Y) studied, did not affect neuronal projections (Table S3 ). Paradoxically, some mutants exhibited increased secretion in cells. Experiments in chick DRGs have shown that the concentration of SEMA3s can determine which signaling pathway is activated and thereby influence the extent of growth cone collapse within a < 100 ng/mL to > 625 ng/mL range (Manns et al., 2012) . As such, mutants that both increase and decrease secretion might disrupt axon guidance in vivo. Understanding how ligand concentration (as altered by human variants) affects axon growth may provide insights into the development of hypothalamic and extra-hypothalamic circuits in the human brain.
Mutant PLXN receptors were predominantly found within the endoplasmic reticulum rather than at the cell surface; structural modeling of the 21 mutants in PLXNAs and NRPs suggested several explanations for the misfolding of mutant receptors. The downstream consequences of aberrant receptor expression and signaling are challenging to predict as different NRP-PLXN complexes mediate signaling by different combinations of Semaphorins in different brain regions. For example, experiments in neurons suggest that Sema3A signals via Nrp1-PlxnA4 complexes, whereas Nrp2-PlxnA3 complexes mediate responses to Sema3F. Studies in PlxnA3-null mice show that PlxnA3 can mediate the effects of Sema3A and Sema3F (Cheng et al., 2001) . However, neurons from PlxnA3-null mice only partially lose responses to Sema3A implying a degree of compensation through other receptor complexes, whereas hippocampal neurons from these mice lose essentially all responsiveness to Sema3F implying there is no redundant receptor for this specific response.
In preliminary studies, we modeled the effects of two NRP1 and -2 variants on melanocortin neural circuits in zebrafish. Compared to WT NRP2, A506V NRP2 resulted in a significant further reduction in the density of a-MSH-labeled fibers in the preoptic area (teleost homolog of the PVH) ( Figure S3C ). Compared to WT NRP1, the R237Q NRP1 mutant resulted in a further reduction in the density of AgRP immunoreactive fibers innnervating the anterior tuberal nucleus (teleost homolog of the VMH) ( Figure S3C ). Given the challenges associated with dissecting the impact of these molecules on neuronal circuits and weight-related phenotypes, deletion/reactivation studies of components of the signaling pathway in specific neuronal populations will be needed to determine the extent to which other components of the signaling complex can compensate for the partial lack of expression of mutant receptors in vivo.
Role of SEMA3 Signaling in the Development of Hypothalamic Neural Circuits
Our data suggest that Sema3 signaling in developing Pomc neurons contributes to the regulation of energy homeostasis and glucose homeostasis. The relatively modest effect of Nrp2 deletion in Pomc neurons on body weight is not surprising, as only Pomc axonal projections to the PVH were disrupted in this mouse model. Our findings align with experiments specifically disrupting leptin signaling in ARH Pomc neurons (Berglund et al., 2012) . Further in-depth exploration of the degree of compensation/plasticity associated with targeted experimental manipulations will be needed. Further characterization of the impact of human variants in mature neurons, where they can affect the maturation and density of dendritic spines, synaptogenesis, and synaptic plasticity (Orr et al., 2017) , may inform understanding of the mechanisms that underlie human disorders characterized by hypothalamic dysfunction.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: male, mean BMI or BMI SDS did not differ between males and females (35.3 ± 3.4 kg/m 2 versus 34.9 ± 1.8 kg/m 2 ; 3.8 ± 0.2 SDS versus 3.8 ± 0.2 SDS). All studies were approved by the Cambridge Local Research Ethics Committee and each subject (or their parent for those under 16 years) provided written informed consent; minors provided oral consent. Healthy blood donors from the INTERVAL project were used as controls (Moore et al., 2014) . All participants gave informed written consent.
Studies in cellular models HEK293 (XX female) and COS7 (XY male) cells were cultured in high glucose Dulbecco's modified eagle medium (DMEM, GIBCO, 41965) supplemented with 10% fetal bovine serum (FBS, GIBCO, 10270, South America origin), 1% GlutaMAX (100X) (GIBCO, 35050) , and 100 units/mL penicillin and 100 mg/mL streptomycin (Sigma-Aldrich, P0781). U87MG (XY male) cells were cultured in MEM with non-essential amino acids (Sigma) supplemented with 10% FBS (GIBCO), 1mM Sodium pyruvate, 1% GlutaMAX (100X) (GIBCO, 35050) , and 100 units/mL penicillin and 100 mg/mL streptomycin (Sigma-Aldrich, P0781). HUVECs (XX, female) cells were cultured in M199 (with Glutamine) (Sigma-Aldrich, M4530), supplemented with 20% FBS (GIBCO), 1% GlutaMAX (100X) (GIBCO, 35050), 100 units/mL penicillin and 100 mg/mL streptomycin (Sigma-Aldrich, P0781), 1% Vitamins-MEM-EAGLE Vitamin Solution (GIBCO, 11120052) . HUVEC cells were grown in flasks coated with gelatin (Sigma-Aldrich, G1890). U87MG and HUVEC cells were a kind gift from Gera Neufeld (the Rappaport Institute). Cells were incubated at 37 C in humidified air containing 5% CO 2 and transfections were performed using Lipofectamine 2000 (GIBCO, 11668) in serum-free Opti-MEM I medium (GIBCO, 31985) according to the manufacturer's protocols.
Studies in zebrafish
All zebrafish experiments were conducted in accordance with the Animals (Scientific Procedures) Act 1986, and following UK Home Office approval (License #: P0662C816). Using CRISPR/Cas9, deletion mutants of zebrafish homologs of Semaphorin3s, PlexinA1-4 and Nrp1-2 were generated and characterized by their length and weight. Zebrafish were reared at equivalent densities and the analyses were conducted prior to any overt sexual differentiation.
Studies in mice
All animal procedures were conducted in compliance with and approved by the IACUC of the Saban Research Institute of the Children's Hospital of Los Angeles. Animals were housed under specific pathogen-free conditions, maintained in a temperaturecontrolled room with a 12 h light/dark cycle, and provided ad libitum access to water and standard laboratory chow (Special Diet Services). To genetically label Pomc fibers for in vitro studies, Pomc-Cre mice (Balthasar et al., 2004) were crossed with a ROSA-TdTomato reporter line (Madisen et al., 2010) . To generate Pomc-specific Nrp2 knockout (Pomc-Cre; Nrp2 loxP/loxP ) mice, Pomc-Cre mice were mated to mice carrying a loxP-flanked Nrp2 allele (Nrp2 loxP/loxP ) (Walz et al., 2002) . Breeding colonies were maintained by mating Pomc-Cre; Nrp2 loxP/+ mice to Nrp2 loxP/loxP mice. Cre-negative Nrp2 loxP/loxP were used as controls. All mice were generated in a C57BL/6 background and only male mice were studied.
METHOD DETAILS
Studies in Humans
Sequencing, variant calling, and quality control Details about sequencing and variant calling for the severe childhood onset obesity project (SCOOP, UK individuals of European ancestry recruited to the GOOS cohort) cases (Hendricks et al., 2017) , as part of the UK10K exomes, and the INTERVAL controls have been reported previously (Singh et al., 2016 (Price et al., 2006) to identify non-Europeans, and pairwise identity by descent estimates from PLINK v1.07 (Purcell et al., 2007) with a threshold of R 0.125 to identify related individuals. Contaminated, non-European, and related samples were removed resulting in 927 SCOOP cases and 4,057 INTERVAL controls for analysis.
Gene-set enrichment
We performed gene-set enrichment similar to previous analyses described in (Purcell et al., 2014; Singh et al., 2016) . Briefly, using PLINK/SEQ (Purcell et al., 2007) we calculated individual gene region burden test-statistics for an enrichment in cases compared to controls of very rare (MAF < 0.025%) variants meeting one of two predicted functional requirements: functional or loss of function, or only loss of function. We then used the SMP utility to calculate the gene set enrichment while controlling for exome-wide differences between cases and controls. Twenty thousand case control permutations were used to estimate the empirical gene set enrichment p value on which a Bonferroni adjustment for two tests (i.e., functional and LoF, and LoF only) was applied to arrive at the adjusted p value.
Functional Characterization of Rare Human Variants
Cloning and site-directed mutagenesis The cDNA constructs used throughout the study were made by site-directed mutagenesis using QuikChange II XL kit (Agilent Technologies, 200516) according to the manufacturer's protocols. SEMA3s cDNA constructs contained a C-terminal Myc/DDK tag; NRP1-2 and PLXNA1-4 cDNA constructs contained a N-terminal Glu-Glu tag and C-terminal Myc/DDK tag; all constructs were ligated into pCMV6-Entry vector (Origene) using Sgf I/Mlu I site. All constructs were verified by Sanger sequencing. SEMA3s secretion, cell surface and total cell ELISA Secreted SEMA3s were detected in the medium of transfected HEK293 cells grown in 96 well plates. Medium from these cells was transferred to MaxiSorp plates and bound SEMA3 immunodetected with an anti-Flag antibody. Cell surface antigen was quantified on transfected non-permeabilised live HEK293 cells in 96 well plates using an anti-Glu-Glu antibody. Total cell antigen was detected in transfected HEK293 cells in 96-well plates after fixation and permeabilisation using an anti-Flag antibody. Secreted Semaphorin ELISA 50,000 HEK293 cells were seeded into each well of a poly-D-lysine coated 96-well plate. After 24hr the cell medium was exchanged for Opti-MEM (GIBCO) and cells transfected. Cell medium was exchanged once more with 50 mL of Opti-MEM containing a 1:400 dilution of Protease inhibitors (Sigma). 48 h after transfection, cell medium from two identically transfected 96-well plates was pooled together (100 ml total volume) with the addition of 25mM HEPES pH7.5 and centrifuged at 1500rpm for 5 min. The top 80 mL of medium was transferred to black MaxiSorp plates (NUNC), the plates were sealed and incubated overnight at 4 o C with gentle agitation. Cell medium was removed and plates were washed thrice for 10 min with gentle agitation before blocking and immunodetection as described in the ELISA procedure below using the anti-Flag antibody and QuantaBlu Fluorogenic Peroxidase Substrate Kit (Thermo). Cell surface and total protein ELISA 40,000 HEK293 cells were seeded into each well of a poly-D-lysine coated 96-well plate and transfected the following day. 48 h after transfection cells were washed once with PBS and processed for the detection of either cell surface or total cellular antigens. Cell surface protein was detected by blocking live cells on ice (3% dry milk, 50mM Tris, pH 7.4 in PBS) for 30 mins and then incubation with anti-Glu-Glu antibody (Covance) in blocking buffer on ice for 2 hr. Cells were washed thrice for 10 min on ice with PBS and then fixed (3.7% formaldehyde in PBS) for 10 min on ice and then 10 min at room temperature. Cells were washed thrice for 10 min with PBS, blocked again for 30 min and incubated with secondary antibody as described for the total cellular antigen detection procedure. Total cellular antigens were detected in fixed (3.7% formaldehyde in PBS) and permeabilised (0.1% triton in PBS for 5 mins) cells after blocking for 1hr and incubation with anti-flag antibody (Sigma) for 2 hr in blocking buffer. Cells were washed thrice for 10 min with PBS, incubated with anti-mouse HRP antibody (BioRad) (1.5% dry milk, 50mM Tris, pH 7.4 in PBS) for 1 hr, washed thrice more for 10 min with PBS before incubation with HRP substrate (TMB, BioRad) and measurement of absorbance at 450nM. Cell collapse assays SEMA3-induced cell collapse was tested in U87MG cells grown on a gelatin coated surface. Cells were exposed to SEMA3-conditioned cell medium and collapsed cells micrographed after 30 min and counted manually. Receptor mutants were tested by transfecting COS7 cells with PLXNA, NRP, and GFP, followed by exposure to purified SEMA3C at 2 mg /ml for 30 min. Collapsed cells were micrographed under blue laser and collapse quantified using ImageJ. Semaphorin expression vectors were transfected into HEK293 cells at 60%-90% confluency in 10cm dishes. Growth medium was replaced with serum-free medium after 12 h. After 48 h the medium, containing secreted semaphorin, was harvested, aliquoted, and snap frozen in liquid nitrogen followed by storage at À80 C. The cell contraction assay with mutant ligands was carried out as reported previously (Sabag et al., 2014) . U87MG cells were used for SEMA3A, SEMA3B, SEMA3D, SEMA3F, and SEMA3G induced collapse. HUVEC cells were used with SEMA3C and SEMA3E. The morning of the assay 10 5 cells/well were seeded into a 12-well plate coated with gelatin (Sigma, UK). Cells were allowed to attach to the plate surface for 5 h. Semaphorin-containing medium was then added to the wells at a 1:2 dilution and cells kept at 37 C for 30 min. Following collapse cells the plates were photographed under the microscope and collapsed cells counted individually (at least 100 cells per well). To test cell collapse mediated by mutant receptors, COS7 cells were seeded at 2x10 5 cells/well in a gelatin coated 6-well plate, and the following day co-transfected with PlxnA1-4, Nrp1-2, and GFP. After 24 h purified, recombinant, human SEMA3C (R&D Systems, UK) was added at a concentration of 2 mg/ml and incubated at 37 C for 30 min. Following collapse, cells were photographed under the microscope and collapsed cells were counted using image recognition software on ImageJ (NIH, Bethesda). Collapse efficiency was assessed by counting the proportion of collapsed cells 30 min following addition of the WT semaphorin to the culture medium. Ligand binding assay Cells expressing NRP1-2 or co-expressing NRP1-2 and PLXNA1-4 were incubated with recombinant human SEMA3C-Fc chimera and binding was quantified using an anti-human IgG (Fc specific) antibody. HEK293 cells (40,000 cells/well) were seeded in a poly-Dlysine coated 96-well plate. After 24 h, 70%-80% confluent cells were transiently transfected with WT or mutant NRP1/2 alone or co-transfected with NRP1/2 (WT and mutant) and WT PLXNA1-4. For NRP and PLXNA constructs, the amount of DNA used was 30 and 60 ng, respectively. Twenty four hours after transfection, cells were blocked with 1% BSA in serum-free media (SFM) for e4 Cell 176, 1-14.e1-e8, February 7, 2019
